| Basics |
| Company: |
Fulcrum Therapeutics, Inc. |
| IPO Date: |
July 15, 2019 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$245.42M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.41 | 4.02%
|
| Avg Daily Range (30 D): |
$0.18 | 4.37%
|
| Avg Daily Range (90 D): |
$0.16 | 3.83%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.64M |
| Avg Daily Volume (30 D): |
.82M |
| Avg Daily Volume (90 D): |
1.27M |
| Trade Size |
| Avg Trade Size (Sh.): |
111 |
| Avg Trade Size (Sh.) (30 D): |
105 |
| Avg Trade Size (Sh.) (90 D): |
134 |
| Institutional Trades |
| Total Inst.Trades: |
603 |
| Avg Inst. Trade: |
$1.56M |
| Avg Inst. Trade (30 D): |
$1.72M |
| Avg Inst. Trade (90 D): |
$1.23M |
| Avg Inst. Trade Volume: |
.18M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.61M |
| Avg Closing Trade (30 D): |
$2.18M |
| Avg Closing Trade (90 D): |
$1.1M |
| Avg Closing Volume: |
179.24K |
|
|
|
|
| News |
Nov 6, 2024 @ 1:00 PM
Fulcrum Therapeutics to Host Third Quarter 2024 Fi...
Source: N/A
|
Oct 11, 2024 @ 8:30 PM
Fulcrum Therapeutics Reports Inducement Grants Und...
Source: N/A
|
Sep 24, 2024 @ 7:08 PM
BHVN Stock Up as Rare Neurological Disease Study M...
Source: Zacks
|
Sep 19, 2024 @ 8:00 PM
FULC INVESTOR ALERT: Bronstein, Gewirtz and Grossm...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Sep 13, 2024 @ 8:00 PM
FULC INVESTOR ALERT: Bronstein, Gewirtz and Grossm...
Source: Bronstein, Gewirtz & Grossman, Llc
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-.29
|
$-.35
|
$.89
|
|
Diluted EPS
|
$-.29
|
$-.35
|
$.87
|
|
Revenue
|
$ 80.87M
|
$ M
|
$ 80M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -17.91M
|
$ -21.7M
|
$ 55.41M
|
|
Operating Income / Loss
|
$ -30.46M
|
$ -25.13M
|
$ 52.49M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 42.66M
|
$ -14.09M
|
$ 46.77M
|
|
PE Ratio
|
|
|
|
|
